Skip to main content

Table 1 Baseline characteristics of the patients (mean ± SD, for non-parametric values: median, inter-quartile range) p compared to normal.

From: Myocardial tissue Doppler echocardiography and N-terminal B-type natriuretic peptide (NT-proBNP) in diastolic and systolic heart failure

 

All patients (n= 137)

Normal (n= 42)

Diastolic dysfunction (n = 43)

Systolic dysfunction (n = 52)

p (compared to normal)

Male sex (%)

88 (65)

23 (55)

23 (54)

43 (83)

1.00/0.0059

Age [y]

53.8 (± 18.1)

37.8 (± 15.9)

62.7 (± 12.5)

59.5 (± 15.2)

< 0.0001/< 0.0001

BMI [kg/m2]

25.54 (± 4.36)

23.8 (± 3.4)

26.5 (± 3.8)

26.2 (± 5.1)

0.011/0.018

NT-proBNP [pg/ml]

2378 ± 6253, (median 222 (± 1220)

275.9 ± 519.9 (median 66.8, ± 185.3)

255.9 ± 137.4(median 137, ± 256.7)

5832 ± 9185(median 1583, ± 5109)

0.36/<0.0001

Creatinine clearance [ml/min]

87.48 (± 37.89)

107.9 (± 28.6)

82.1 (± 35.0)

78.5 (± 41.3)

0.003/0.0002

Heart rate [/s]

71.6 (± 13.6)

68.3 (± 13.9)

73.1 (± 13.1)

73.5 (± 13.5)

0.68/0.17

Systolic RR [mmHg]

123.0

123.0

136.8

115.4

0.01/0.19

Diastolic RR [mmHg]

74.0

75.4

80.0

71.2

0.21/0.23

coronary artery disease (%)

41 (30)

1 (2)

10 (23)

28 (54)

0.0077/0.001

previous myocardial infarction (%)

28 (20)

0

5 (12)

21 (40)

0.06/0.0001

arterial hypertension (%)

63 (46)

11 (26)

27 (63)

25 (48)

0.0008/0.049

diabetes mellitus (%)

25 (18)

3 (7)

3 (7)

18 (35)

1.00/0.0046

Hyperlipidemia (%)

40 (29)

2 (5)

15 (35)

22 (42)

0.0018/< 0.0001

Smoker (%)

27 (20)

10 (24)

9 (21)

9 (17)

0.8035

ischemic cardiomyopathy (%)

30 (22)

0

0

29 (56)

< 0.0001